United States · FDA National Drug Code directory
CANTHARIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 15631-0105_caa1398e-ab39-4ae6-e053-2995a90a0c18
- Product NDC
- 15631-0105
- Form
- PELLET
- Composition / generic term
- CANTHARIS
- Labeler
- Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20151006
- Source listing expiry
- 20261231
Source-listed ingredients
- LYTTA VESICATORIA — 3 [hp_X]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 PELLET in 1 PACKAGE (15631-0105-0) · 15631-0105-0
- 200 PELLET in 1 PACKAGE (15631-0105-1) · 15631-0105-1
- 400 PELLET in 1 PACKAGE (15631-0105-2) · 15631-0105-2
- 750 PELLET in 1 PACKAGE (15631-0105-3) · 15631-0105-3
- 2500 PELLET in 1 PACKAGE (15631-0105-4) · 15631-0105-4
- 12500 PELLET in 1 PACKAGE (15631-0105-5) · 15631-0105-5
- 500 PELLET in 1 PACKAGE (15631-0105-6) · 15631-0105-6
- 1000 PELLET in 1 PACKAGE (15631-0105-7) · 15631-0105-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →